Spago Nanomedical
BioStock: Spago Nanomedical's promising cancer therapy approved for phase I/IIa
Read the interview with Mats Hansen at biostock.se:
Spago Nanomedical's promising cancer therapy approved for phase I/IIa - BioStock
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
Datum | 2023-10-23, kl 08:46 |
Källa | Cision |
![](https://static.allaaktier.se/ads/etoro-logo.png)
Copy Trading innebär inte investeringsråd. Värdet på dina investeringar kan gå upp eller ned. Ditt kapital löper risk.